JP Morgan Reiterates Overweight Rating on Alignment Healthcare, Inc. (ALHC)

Market Context

Alignment Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $7.54 with a market capitalization of $3.8B. The stock has declined 57.4% over the past 52 weeks.

Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Alignment Healthcare, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Alignment Healthcare, Inc.

Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 09, 2026	William Blair	Market Perform	N/A
Oct 09, 2026	JP Morgan	Overweight	N/A
Oct 09, 2026	Keybanc	Overweight	N/A
Oct 06, 2026	Barclays	Equal-Weight	N/A
Aug 04, 2026	JP Morgan	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View ALHC Stock Page